You are here: Welcome » COVID-19 Vaccines » Adverse Events Following COVID-19 Vaccination » COVID-19 Vaccine Associated Guillain-Barré Syndrome

Menu

Rounding The Earth

Operation Uplift

Project List

Table of Contents

COVID-19 Vaccine Associated Guillain-Barré Syndrome

Peer-Reviewed Scientific papers regarding COVID-19 Vaccine Associated Guillain-Barré Syndrome

GM1 ganglioside antibody and COVID-19-related Guillain Barre syndrome: case report, systemic review, and implications for vaccine development

Guillain-Barré syndrome after AstraZeneca COVID-19 vaccination: causal or casual association

Sensory Guillain-Barré syndrome after ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature

Guillain-Barré syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association.

Guillain-Barré syndrome presenting as facial diplegia after vaccination with COVID-19: a case report

Guillain-Barré syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report.

SARS-CoV-2 vaccines are not safe for those with Guillain-Barre syndrome following vaccination

Guillian Barré syndrome after vaccination with mRNA-1273 against COVID-19

A novel case of bifacial diplegia variant of Guillain-Barré syndrome after vaccination with Janssen COVID-19

Sensory Guillain-Barré syndrome following ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature.

Facial diplegia: a rare and atypical variant of Guillain-Barré syndrome and the Ad26.COV2.S vaccine

Guillain-Barré syndrome after ChAdOx1 nCoV-19 COVID-19 vaccination: a case series

AstraZeneca COVID-19 vaccine and Guillain-Barré syndrome in Tasmania: a causal link

COVID-19, Guillain-Barré and vaccineA dangerous mix.

Guillain-Barré syndrome after the first dose of Pfizer-BioNTech COVID-19 vaccine: case report and review of reported cases.

Guillain-Barre syndrome after BNT162b2 COVID-19 vaccine.

COVID-19 adenovirus vaccines and Guillain-Barré syndrome with facial palsy.

Association of receipt association of Ad26.COV2.S COVID-19 vaccine with presumed Guillain-Barre syndrome, February-July 2021

A case of Guillain-Barré syndrome after Pfizer COVID-19 vaccine

Guillain-Barré syndrome associated with COVID-19 vaccination.

Rate of recurrent Guillain-Barré syndrome after COVID-19 BNT162b2 mRNA vaccine

Guillain-Barre syndrome after COVID-19 vaccination in an adolescent.

Guillain-Barre syndrome after ChAdOx1-S / nCoV-19 vaccination.

Guillain-Barre syndrome after COVID-19 mRNA-1273 vaccine: case report.

Guillain-Barre syndrome following SARS-CoV-2 vaccination in 19 patients.

Guillain-Barre syndrome presenting with facial diplegia following vaccination with COVID-19 in two patients

A rare case of Guillain-Barré syndrome after COVID-19 vaccination

Neurological complications of COVID-19: Guillain-Barre syndrome after Pfizer COVID-19 vaccine

COVID-19 vaccine causing Guillain-Barre syndrome, an uncommon potential side effect

Guillain-Barre syndrome after the first dose of COVID-19 vaccination: case report

Guillain-Barre syndrome after the first injection of ChAdOx1 nCoV-19 vaccine: first report.

A case of sensory ataxic Guillain-Barre syndrome with immunoglobulin G anti-GM1 antibodies after first dose of COVID-19 BNT162b2 mRNA vaccine (Pfizer)

A variant of Guillain-Barré syndrome after SARS-CoV-2 vaccination: AMSAN.

A rare variant of Guillain-Barré syndrome after vaccination with Ad26.COV2.S.

Guillain-Barré syndrome after SARS-CoV-2 vaccination in a patient with previous vaccine-associated Guillain-Barré syndrome

Guillain-Barré syndrome in an Australian state using mRNA and adenovirus-vector SARS-CoV-2 vaccines

Variant Guillain-Barré syndrome occurring after SARS-CoV-2 vaccination

Guillian-Barre syndrome with axonal variant temporally associated with Modern SARS-CoV-2 mRNA-based vaccine

Guillain-Barre syndrome after the first dose of SARS-CoV-2 vaccine: a temporary occurrence, not a causal association

SARS-CoV-2 vaccines can be complicated not only by Guillain-Barré syndrome but also by distal small fiber neuropathy

Clinical variant of Guillain-Barré syndrome with prominent facial diplegia after AstraZeneca 2019 coronavirus disease vaccine

Miller-Fisher syndrome and Guillain-Barré syndrome overlap syndrome in a patient after Oxford-AstraZeneca SARS-CoV-2 vaccination

Bilateral facial weakness with a variant of paresthesia of Guillain-Barre syndrome after Vaxzevria COVID-19 vaccine

Back to top